tiprankstipranks
Keros Therapeutics price target lowered to $47 from $100 at H.C. Wainwright
PremiumThe FlyKeros Therapeutics price target lowered to $47 from $100 at H.C. Wainwright
27d ago
BofA cuts Keros target to $33, says ‘story still intact’ despite ‘setback’
Premium
The Fly
BofA cuts Keros target to $33, says ‘story still intact’ despite ‘setback’
28d ago
Keros Therapeutics downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Keros Therapeutics downgraded to Hold from Buy at TD Cowen
28d ago
Keros Therapeutics presents clinical data from Elritercept program at ASH
PremiumThe FlyKeros Therapeutics presents clinical data from Elritercept program at ASH
1M ago
Keros Therapeutics management to meet with Oppenheimer
Premium
The Fly
Keros Therapeutics management to meet with Oppenheimer
1M ago
Takeda, Keros Therapeutics enter exclusive elritercept license agreement
Premium
The Fly
Takeda, Keros Therapeutics enter exclusive elritercept license agreement
1M ago
Keros Therapeutics to Present at Guggenheim Conference
PremiumCompany AnnouncementsKeros Therapeutics to Present at Guggenheim Conference
2M ago
Jefferies starts Keros with Buy, sees potential $2B in peak sales
Premium
The Fly
Jefferies starts Keros with Buy, sees potential $2B in peak sales
2M ago
Keros Therapeutics initiated with a Buy at Jefferies
Premium
The Fly
Keros Therapeutics initiated with a Buy at Jefferies
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100